Harrow
HROW
30.62
+0.27
+0.89%
Harrow
US · HROW
#3155 by market cap
30.62
+0.27
+0.89%
Live - 5344 symbols - heartbeat 517s ago
· 2026-10-08 09:03
Pre-market
30.55
-0.23%
After-hours
31.12
+1.63%
Overnight
30.69
+0.23%
- Market cap
- 1.15B
- P/E (TTM)i
- -30.93
- P/Bi
- 75.60
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on HROW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.71, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +36.41% YoY
Margins
- Gross margin
- 75.05%
- Operating margin
- 11.21%
- Net margin
- -1.89%
Key ratios & quality
- Enterprise valuei
- 1.32B
- Altman Z-Scorei
- 2.71
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 41.37M | 51.17M | 48.87M | 72.48M | 88.60M | 130.19M | 199.61M | 272.30M |
| Gross profit | 24.85M | 34.42M | 34.41M | 54.26M | 63.21M | 90.55M | 150.37M | 204.37M |
| Selling & admin expenses | 29.24M | 33.09M | 31.25M | 41.32M | 58.24M | 83.09M | 129.06M | 152.91M |
| Research & development | 825.00K | 2.08M | 2.41M | 11.08M | 3.05M | 6.65M | 12.23M | 20.94M |
| Operating profit | -5.22M | -755.00K | 748.00K | 1.86M | 1.92M | 811.00K | 9.08M | 30.52M |
| Pretax profit | 14.63M | -117.00K | -3.42M | -17.87M | -14.01M | -23.71M | -17.32M | -1.37M |
| Tax | 0 | 8.00K | 4.00K | 133.00K | 75.00K | 701.00K | 161.00K | 3.77M |
| Net profit | 14.63M | -125.00K | -3.42M | -18.01M | -14.09M | -24.41M | -17.48M | -5.14M |
| Basic EPS | 1 | 0 | 0 | -1 | -1 | -1 | 0 | 0 |
| Diluted EPS | 0.61 | 0.01 | -0.13 | -0.69 | -0.51 | -0.75 | -0.49 | -0.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 47.83M | 63.74M | 71.64M | 89.09M | 44.20M | 70.66M |
| Gross profit | 32.31M | 47.51M | 53.93M | 70.62M | 27.05M | 50.36M |
| Selling & admin expenses | 40.51M | 33.24M | 35.86M | 43.31M | 43.23M | 53.30M |
| Research & development | 3.03M | 2.87M | 3.32M | 11.72M | 5.90M | 8.07M |
| Operating profit | -11.23M | 11.41M | 14.75M | 15.59M | -22.08M | -11.01M |
| Pretax profit | -17.78M | 5.00M | 1.02M | 10.40M | -27.58M | -17.27M |
| Tax | -- | 0 | 0 | 3.77M | 25.00K | 0 |
| Net profit | -17.78M | 5.00M | 1.02M | 6.63M | -27.60M | -17.27M |
| Basic EPS | -1 | 0 | 0 | 0 | -1 | 0 |
| Diluted EPS | -0.50 | 0.13 | 0.03 | 0.17 | -0.74 | -0.46 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 32.84M | 36.05M | 40.98M | 60.66M | 118.26M | 139.48M | 189.65M | 211.75M |
| Cash & ST investments | 28.06M | 29.95M | 32.56M | 50.67M | 101.86M | 82.77M | 47.25M | 72.93M |
| Inventory | 1.83M | 3.30M | 3.96M | 4.22M | 6.54M | 10.87M | 10.70M | 13.52M |
| Total assets | 49.45M | 59.09M | 57.47M | 98.33M | 157.38M | 312.16M | 388.97M | 399.48M |
| Total current liabilities | 11.90M | 12.28M | 10.80M | 9.72M | 18.63M | 49.34M | 91.34M | 96.30M |
| Short-term debt | 3.25M | 2.41M | 4.49M | 280.00K | 723.00K | 806.00K | 497.00K | 887.00K |
| Long-term debt | 12.00M | 12.22M | 12.38M | 71.65M | 104.17M | 185.89M | 219.54M | 243.18M |
| Total liabilities | 24,700,000.00 | 31,667,000.00 | 30,646,000.00 | 87,398,000.00 | 130,138,000.00 | 241,753,000.00 | 319,674,000.00 | 347,391,000.00 |
| Total equity | 24.75M | 27.42M | 26.83M | 10.93M | 27.24M | 70.41M | 69.30M | 52.09M |
| Retained earnings | -74.21M | -74.04M | -77.40M | -95.41M | -109.49M | -133.90M | -151.39M | -156.52M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 169.54M | 154.89M | 177.60M | 211.75M | 226.38M | 229.31M |
| Cash & ST investments | 66.73M | 52.96M | 74.29M | 72.93M | 94.64M | 83.89M |
| Inventory | 10.72M | 11.55M | 12.83M | 13.52M | 16.50M | 16.91M |
| Total assets | 364.16M | 345.03M | 363.07M | 399.48M | 419.54M | 416.82M |
| Total current liabilities | 186.99M | 248.88M | 65.40M | 96.30M | 91.44M | 102.17M |
| Short-term debt | 108.92M | 184.40M | 859.00K | 887.00K | 915.00K | 944.00K |
| Long-term debt | 112.50M | 38.48M | 242.87M | 243.18M | 292.09M | 292.38M |
| Total liabilities | 308,068,000.00 | 295,734,000.00 | 316,413,000.00 | 347,391,000.00 | 391,192,000.00 | 401,971,000.00 |
| Total equity | 56.10M | 49.30M | 46.66M | 52.09M | 28.35M | 14.85M |
| Retained earnings | -169.17M | -164.17M | -163.15M | -156.52M | -184.13M | -201.40M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 687.00K | 950.00K | -1.10M | 5.08M | 1.71M | 3.84M | -22.20M | 43.86M |
| Depreciation & amortization | 1.84M | 2.66M | 2.74M | 2.40M | 3.67M | 12.34M | 14.54M | 19.68M |
| Free cash flow | -1.52M | -887.00K | -2.09M | -23.43M | -6.07M | -148.71M | -60.88M | 42.76M |
| Dividends paid | -- | -- | -- | -127.00K | -- | -- | -- | -- |
| Stock buybacks / issuance | 642.00K | -- | -- | 0 | 22.66M | 138.07M | 0 | 0 |
| Ending cash balance | 6.84M | 4.95M | 4.30M | 42.17M | 96.27M | 74.09M | 47.25M | 72.93M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 19.67M | -803.00K | 16.59M | 8.41M | -8.99M | -9.76M |
| Depreciation & amortization | 4.91M | 4.90M | 4.90M | 4.97M | 5.78M | 6.18M |
| Free cash flow | 19.46M | -1.10M | 16.36M | 8.04M | -27.20M | -10.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 66.73M | 52.96M | 74.29M | 72.93M | 94.64M | 83.89M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 106.88 | 0.64 | -12.23 | -96.07 | -72.46 | -49.64 | -24.90 | -8.42 |
| ROA %i | 39.87 | 0.31 | -5.76 | -23.72 | -11.02 | -10.40 | -4.99 | -1.30 |
| ROIC %i | 50.48 | 0.38 | -6.75 | -26.41 | -12.30 | -4.28 | -0.19 | 4.27 |
| 5-year avg ROE %i | -294.29 | -276.77 | -185.21 | -53.15 | -14.65 | -45.95 | -51.06 | -50.30 |
| EBIT margin %i | -12.61 | -1.49 | 1.53 | 2.57 | 2.17 | -1.83 | 2.74 | 8.38 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | 15.70 |
| Current ratioi | 2.76 | 2.93 | 3.79 | 6.24 | 6.35 | 2.83 | 2.08 | 2.20 |
| Quick ratioi | 2.52 | 2.60 | 3.34 | 5.68 | 5.81 | 2.42 | 1.79 | 1.91 |
| Debt / assetsi | 30.83 | 35.53 | 40.95 | 79.28 | 71.31 | 61.90 | 58.83 | 63.08 |
| LT debt / equityi | 48.48 | 67.06 | 70.07 | 688.25 | 404.08 | 271.89 | 327.82 | 478.76 |
| Interest coveragei | -- | -- | -- | -- | -- | -0.11 | 0.24 | 0.94 |
| Revenue CAGR (3Y) %i | 62.08 | 36.90 | 22.21 | 20.55 | 20.08 | 38.63 | 40.17 | 45.39 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -37.08 | -18.91 | -9.50 | -8.42 | -35.14 | -114.80 |
| ROA %i | -6.58 | -3.14 | -1.40 | -1.30 | -3.82 | -9.77 |
| ROIC %i | 0.83 | 5.07 | 6.51 | 4.27 | 2.65 | -7.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.12 | 6.21 | 7.95 | 8.38 | 4.45 | -3.79 |
| FCF / sales %i | -- | -- | -- | 15.70 | -- | -- |
| Current ratioi | 0.91 | 0.62 | 2.72 | 2.20 | 2.48 | 2.24 |
| Quick ratioi | 0.77 | 0.53 | 2.33 | 1.91 | 2.14 | 1.98 |
| Debt / assetsi | 63.16 | 67.02 | 69.37 | 63.08 | 71.67 | 72.15 |
| LT debt / equityi | 214.49 | 94.35 | 533.89 | 478.76 | 1,044.22 | 1,972.37 |
| Interest coveragei | 0.10 | 0.57 | 0.78 | 0.94 | 0.52 | -0.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Branded is the largest reported line at 79.40% of revenue, across 2 reported segments.
- The next-largest line, Compounding, is a distant second at 20.60% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Branded79.40%
Compounding20.60%
Quote time 2026-10-08 09:03:56 · For reference only, not investment advice and not tailored to your situation.